Involvement of Nuclear Receptors PPAR-α, PPAR-γ, and the Transcription Factor Nrf2 in Cellular Protection Against Oxidative Stress Induced by Hypoxia-Reoxygenationand High Glucose, Regulated by H2S in Primary Cardiomyocyte Cultures
Authors:
- Luz Ibarra-LaraLuz Ibarra-Lara
- Araceli Sánchez-LópezAraceli Sánchez-López
- Leonardo del Valle-MondragónLeonardo del Valle-Mondragón
- Elizabeth Soria-CastroElizabeth Soria-Castro
- Gabriela Zarco-OlveraGabriela Zarco-Olvera
- Mariana Patlán-MMariana Patlán-M
- Verónica Guarner-LansVerónica Guarner-Lans
- Juan Carlos Torres-NarváezJuan Carlos Torres-Narváez
- Angelica Ruíz-RamírezAngelica Ruíz-Ramírez
- Fernando Díaz de León-SánchezFernando Díaz de León-Sánchez
- Victor Hugo Oidor-ChanVictor Hugo Oidor-Chan
- Vicente Castrejón-TéllezVicente Castrejón-Téllez
Preprint
- 20 January 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Under conditions of hyperglycemia and ischemia/reperfusion (I/R) injury, myocardial oxidative stress increases, leading to cellular damage. Inhibition of oxidative stress has been reported to be involved in the cardioprotective effects of hydrogen sulfide (H2S) during I/R and diabetes. Recent studies have shown that H2S has the potential to protect the heart. However, the mechanism by which H2S regulates the level of cardiac reactive oxygen species (ROS) during I/R and hyperglycemic conditions remains unclear. Therefore, the objective of this study was to evaluate the cytoprotective effect of H2S in primary cardiomyocyte cultures subjected to hyperglycemia, hypoxia/reoxygenation (HR), or both conditions, by assessing the PPAR-α/Keap1/Nrf2/p47phox/NOX4/p-eNOS/CAT/SOD signaling pathway and the PPAR-γ/PGC1α/AMPK/GLUT4 signaling pathway. Treatment with NaHS (100 μM) as an H2S donor in cardiomyocytes subjected to hyperglycemia, HR, or a combination of both experimental conditions increased cell viability, total antioxidant capacity, and tetrahydrobiopterin (BH4) concentrations, while reducing ROS production, malondialdehyde concentrations, 8-hydroxy-2´-deoxyguanosine, and dihydrobiopterin (BH2) concentrations. Additionally, H2S donor treatment increased the expression and activity of PPAR-α, reversed the reduction in the expression of PPAR-γ, PGC1α, AMPK, GLUT4, Nrf2, p-eNOS, SOD and CAT, and decreased the expression of Keap1, p47phox y NOX4. Treatment with the H2S donor protects cardiomyocytes from damage caused by hyperglycemia, HR, or both conditions by reducing oxidative stress markers and improving antioxidant mechanisms, thereby increasing cell viability and cardiomyocyte ultrastructure.Keywords
All Related Versions
This publication has 18 references indexed in Scilit:
- Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11/GSH/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activationRedox Biology, 2024
- Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectivesFree Radical Biology and Medicine, 2022
- The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseasesCurrent Opinion in Pharmacology, 2022
- The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer’s Disease and Other Neurodegenerative DisordersNeurochemical Research, 2020
- ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotectionFree Radical Biology and Medicine, 2018
- Exogenous hydrogen sulfide attenuates diabetic myocardial injury through cardiac mitochondrial protectionMolecular and Cellular Biochemistry, 2012
- Estrogen Prevents Cardiomyocyte Apoptosis through Inhibition of Reactive Oxygen Species and Differential Regulation of p38 Kinase IsoformsJournal of Biological Chemistry, 2006
- Correlation between cardiovascular disease and diabetes mellitus: current conceptsThe American Journal of Medicine, 2004
- Determination of 8-hydroxy-2′-deoxyguanosine in untreated urine by capillary electrophoresis with UV detectionJournal of Chromatography A, 2003
- Fluorometric assay for rat liver peroxisomal fatty acyl-coenzyme A oxidase activity.Journal of Lipid Research, 1983